Kobe – A hospital said Thursday it has performed the world’s first clinical trial of a transplant of photoreceptor cells derived from induced pluripotent stem cells, or iPS cells, to treat a patient with pigmentary retinal degeneration.
Kobe City Eye Hospital in Hyogo Prefecture conducted the clinical trial on a patient with the disease, which can cause vision problems including trouble seeing at night due to a progressive loss of photoreceptor cells in the retina.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.